ArticleGut microbes2016

Limited prolonged effects of rifaximin treatment on irritable bowel syndrome-related differences in the fecal microbiome and metabolome.

Natalia Zeber-Lubecka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.